de Araújo Washington Candeia, Falcão Raul Maia, Uchoa Raquel Araujo Costa, Garcia Carlos Alexandre, da Silva Arthur Quintiliano Bezerra, Quirino Kesia Larissa Medeiros, Freire-Neto Francisco Paulo, Gurgel Genilson Pereira, Nascimento Paulo Ricardo Porfirio, Ferreira Leonardo Capistrano, Duggal Priya, de Souza Jorge Estefano S, Jeronimo Selma M B
Institute of Tropical Medicine of Rio Grande do Norte, Federal University of Rio Grande do Norte, Natal, RN, Brazil.
Department of Biochemistry, Biosciences Center, Federal University of Rio Grande do Norte, Natal, RN, Brazil.
BMC Genomics. 2025 Apr 2;26(1):331. doi: 10.1186/s12864-025-11466-4.
Alport syndrome is a progressive and hereditary nephropathy characterized by hematuria and proteinuria as well as extra renal manifestations as hearing loss and eye abnormalities. The disease can be expressed as autosomal recessive or autosomal dominant at COL4A3 and COL4A4 loci, respectively, or X-linked at the COL4A5 locus. This study investigated two unrelated families with nephropathy from Brazil with the aim to identify the mutations involved with the disease.
Whole Exome Sequencing was performed for 4 people from each pedigree (case, parents and a sibling). DNA sequences were mapped against the human genome (GRCh38/hg38 build) to identify associated mutations.
Two novel deleterious variants in COL4A3 and COL4A4 loci on chromosome 2 were identified. The variants were detected in the probands with mutant alleles in the homozygous state, a premature stop codon at position 481 of COL4A3 protein and a frameshift mutation leading to a stop codon at position 786 of COL4A4 protein. For both Alport cases the putative variants were surrounded by broad Runs of Homozygosity as well as genes associated with other hereditary nephropathies. Genotyping for COL4A3 validated the exome findings.
Two novel variants were identified in two unrelated families from northeast of Brazil. The two deleterious variants identified are located on ROH´s locus with all variants in a homozygous state.
奥尔波特综合征是一种进行性遗传性肾病,其特征为血尿、蛋白尿以及听力丧失和眼部异常等肾外表现。该疾病在COL4A3和COL4A4基因座分别表现为常染色体隐性遗传或常染色体显性遗传,在COL4A5基因座表现为X连锁遗传。本研究调查了来自巴西的两个无亲缘关系的肾病家族,旨在确定与该疾病相关的突变。
对每个家系的4人(患者、父母和一个兄弟姐妹)进行全外显子组测序。将DNA序列与人基因组(GRCh38/hg38版本)进行比对,以识别相关突变。
在2号染色体的COL4A3和COL4A4基因座中鉴定出两个新的有害变异。这些变异在先证者中以纯合状态的突变等位基因形式被检测到,一个是COL4A3蛋白第481位的提前终止密码子,另一个是导致COL4A4蛋白第786位出现终止密码子的移码突变。对于这两例奥尔波特综合征病例,推定的变异均被广泛的纯合子区域以及与其他遗传性肾病相关的基因所包围。COL4A3基因分型验证了外显子组的研究结果。
在巴西东北部的两个无亲缘关系的家族中鉴定出两个新的变异。所鉴定的两个有害变异位于纯合子区域的基因座上,所有变异均处于纯合状态。